| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ruxolitinib | CTRPv2 | pan-cancer | AAC | -0.0014 | 1 |
| mRNA | NVP-ADW742 | CTRPv2 | pan-cancer | AAC | 0.0014 | 1 |
| mRNA | OSI-930 | CTRPv2 | pan-cancer | AAC | 0.0015 | 1 |
| mRNA | GW 441756 | GDSC1000 | pan-cancer | AAC | -0.0015 | 1 |
| mRNA | BIRB 0796 | FIMM | pan-cancer | AAC | 0.0066 | 1 |
| mRNA | carboplatin:etoposide (40:17 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0011 | 1 |
| mRNA | Vandetanib | FIMM | pan-cancer | AAC | -0.006 | 1 |
| mRNA | BRD-K27986637 | CTRPv2 | pan-cancer | AAC | 0.0026 | 1 |
| mRNA | BRD8958 | CTRPv2 | pan-cancer | AAC | -0.0013 | 1 |
| mRNA | SGC0946 | GDSC1000 | pan-cancer | AAC | -0.0012 | 1 |